These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2984980)

  • 21. Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family setting.
    Douglas RM; Moore BW; Miles HB; Davies LM; Graham NM; Ryan P; Worswick DA; Albrecht JK
    N Engl J Med; 1986 Jan; 314(2):65-70. PubMed ID: 3001518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon.
    Hayden FG; Albrecht JK; Kaiser DL; Gwaltney JM
    N Engl J Med; 1986 Jan; 314(2):71-5. PubMed ID: 3001519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Literature review: the common cold.
    Hilding DA
    Ear Nose Throat J; 1994 Sep; 73(9):639-43, 46-7. PubMed ID: 7988393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirus.
    Heinz BA; Vance LM
    J Virol; 1995 Jul; 69(7):4189-97. PubMed ID: 7769678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rhinoviruses and coronaviruses - virological aspects of their role in causing colds in man.
    Tyrrell DA
    Eur J Respir Dis Suppl; 1983; 128 (Pt 1)():332-5. PubMed ID: 6311602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial.
    Turner RB; Wecker MT; Pohl G; Witek TJ; McNally E; St George R; Winther B; Hayden FG
    JAMA; 1999 May; 281(19):1797-804. PubMed ID: 10340366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of rhinovirus colds by human interferon alpha-2 from Escherichia coli.
    Scott GM; Phillpotts RJ; Wallace J; Gauci CL; Greiner J; Tyrrell DA
    Lancet; 1982 Jul; 2(8291):186-8. PubMed ID: 6177991
    [No Abstract]   [Full Text] [Related]  

  • 28. Modification of experimental rhinovirus colds by receptor blockade.
    Hayden FG; Gwaltney JM; Colonno RJ
    Antiviral Res; 1988 Jul; 9(4):233-47. PubMed ID: 2849376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intranasal lymphoblastoid interferon ("Wellferon") prophylaxis against rhinovirus and influenza virus in volunteers.
    Phillpotts RJ; Higgins PG; Willman JS; Tyrrell DA; Freestone DS; Shepherd WM
    J Interferon Res; 1984; 4(4):535-41. PubMed ID: 6094684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence that enviroxime targets multiple components of the rhinovirus 14 replication complex.
    Brown-Augsburger P; Vance LM; Malcolm SK; Hsiung H; Smith DP; Heinz BA
    Arch Virol; 1999; 144(8):1569-85. PubMed ID: 10486111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative studies on the modes of action of the antirhinovirus agents Ro 09-0410, Ro 09-0179, RMI-15,731, 4',6-dichloroflavan, and enviroxime.
    Ninomiya Y; Aoyama M; Umeda I; Suhara Y; Ishitsuka H
    Antimicrob Agents Chemother; 1985 Apr; 27(4):595-9. PubMed ID: 2988431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ineffectiveness of recombinant interferon-beta serine nasal drops for prophylaxis of natural colds.
    Sperber SJ; Levine PA; Sorrentino JV; Riker DK; Hayden FG
    J Infect Dis; 1989 Oct; 160(4):700-5. PubMed ID: 2551976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on 44 081 R.P., a new antirhinovirus compound, in cell cultures and in volunteers.
    Zerial A; Werner GH; Phillpotts RJ; Willmann JS; Higgins PG; Tyrrell DA
    Antimicrob Agents Chemother; 1985 May; 27(5):846-50. PubMed ID: 2990329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphatidylinositol 4-kinase III beta is essential for replication of human rhinovirus and its inhibition causes a lethal phenotype in vivo.
    Spickler C; Lippens J; Laberge MK; Desmeules S; Bellavance É; Garneau M; Guo T; Hucke O; Leyssen P; Neyts J; Vaillancourt FH; Décor A; O'Meara J; Franti M; Gauthier A
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3358-68. PubMed ID: 23650168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intranasal interferon (rIFN-alpha A, Ro 22-8181) for contact prophylaxis against common cold: a randomized, double-blind and placebo-controlled field study.
    Herzog C; Berger R; Fernex M; Friesecke K; Havas L; Just M; Dubach UC
    Antiviral Res; 1986 May; 6(3):171-6. PubMed ID: 3524441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of clarithromycin on experimental rhinovirus-16 colds: a randomized, double-blind, controlled trial.
    Abisheganaden JA; Avila PC; Kishiyama JL; Liu J; Yagi S; Schnurr D; Boushey HA
    Am J Med; 2000 Apr; 108(6):453-9. PubMed ID: 10781777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds.
    Farr BM; Conner EM; Betts RF; Oleske J; Minnefor A; Gwaltney JM
    Antimicrob Agents Chemother; 1987 Aug; 31(8):1183-7. PubMed ID: 2820298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A model for obtaining predictable natural transmission of rhinoviruses in human volunteers.
    Meschievitz CK; Schultz SB; Dick EC
    J Infect Dis; 1984 Aug; 150(2):195-201. PubMed ID: 6088646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intranasal chalcone, Ro 09-0410, as prophylaxis against rhinovirus infection in human volunteers.
    Al-Nakib W; Higgins PG; Barrow I; Tyrrell DA; Lenox-Smith I; Ishitsuka H
    J Antimicrob Chemother; 1987 Dec; 20(6):887-92. PubMed ID: 3326874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation of rhinoviruses and coronaviruses from 38 colds in adults.
    Larson HE; Reed SE; Tyrrell DA
    J Med Virol; 1980; 5(3):221-9. PubMed ID: 6262450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.